Results for: teva+pharmaceuticals

Teva offers to buy Mylan in $40.1B cash-and-stock deal

Top Mylan shareholders seek deal with Teva - sources

Teva's turnaround CEO sets sights on $40 billion mega-deal

Teva offers $40 billion for Mylan

Generic drugmaker Teva makes $40 billion offer for rival Mylan

Yahoo disappoints Wall Street

Facebook revenue growth slows

Wall Street's two major indexes drop oil falls

Ahead of the Bell: Biogen shares keep climbing

Pfizer painkiller gets longer patent protection

FDA accepts application for new Sanofi MS drug

Pharmaceutical giant Teva announces departure of CEO

Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets -...

Ranbaxy, Teva settle New York antitrust drug claims

Gaza raids draw Abbas call for Israel to halt 'escalation'

In quest for next windfall, tech funds look to healthcare

U.S. justices uphold firms' religious objections to contraception

AstraZeneca loses German court appeal over Seroquel XR drug patent

Exclusive: Express Scripts presses for more drug savings with coverage list

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

Stocks climb more than one percent